• General
    Information
    • Welcome Message
    • Virtual Meeting Guide
    • Important Dates
  • Program
    • Program (February 17 – 20)
    • Highlights Europe & Asia
      (March 3 & 4)
    • Industry & Satellite Symposia
  • Promotion,
    Advertising & Exhibits
    • Advertising & Promotion
    • Exhibits
  • Registration
    Now Closed

  • Access the
    Recordings

    • Welcome Message
    • Virtual Meeting Guide
    • Important Dates
    • Press & Media
    • Registration
    • Promotion & Advertising
    • Exhibits
    • Call for Abstracts
    • Program (February 17 – 20)
    • Highlights Europe & Asia
      (March 3 & 4)
    • Industry & Satellite Symposia
MENU
  • Home
  • Join Mailing List
  • IASLC.org
  • Contact Us
  • General
    Information
    • Welcome Message
    • Virtual Meeting Guide
    • Important Dates
  • Program
    • Program (February 17 – 20)
    • Highlights Europe & Asia
      (March 3 & 4)
    • Industry & Satellite Symposia
  • Promotion,
    Advertising & Exhibits
    • Advertising & Promotion
    • Exhibits
  • Registration
    Now Closed

  • Access the
    Recordings

  • Home
  • Join Mailing List
  • IASLC.org
  • Contact Us
  • #TTLC21
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
Conquering Thoracic Cancers Worldwide
  • General
    Information
    • Welcome Message
    • Virtual Meeting Guide
    • Important Dates
  • Program
    • Program (February 17 – 20)
    • Highlights Europe & Asia
      (March 3 & 4)
    • Industry & Satellite Symposia
  • Promotion,
    Advertising & Exhibits
    • Advertising & Promotion
    • Exhibits
  • Registration
    Now Closed

  • Access the
    Recordings

Get Tickets!

PRESS & MEDIA

  • Press & Media

Tweets by IASLC

We welcome media to attend the IASLC 2021 Targeted Therapies of Lung Cancer Meeting (TTLC 2021). Information including a link for registration and details about media policies and embargoes can be found below.

Registration and Media Requirements

Eligibility

  • Companies or organizations producing publications, videos and other products intended for marketing, advertising, financial analysis or public relations purposes may not register to attend the meeting as media.
  • Financial analysts; sales, advertising or marketing representatives; book publishers and book authors may not register as media but are welcome to register as regular attendees.
  • Public relations personnel and individuals from communications, print and online promotion services should register as a regular attendee (not as media).

Journalists, including photographers, must work exclusively for the outlet for which they are credentialed (exceptions for freelance journalists are detailed below). Journalists who use their media privileges to work for non-credentialed organizations will have their privileges revoked. Journalists are required to complete the media online pre-registration form and submit the following:

  • A letter of assignment on the letterhead of the news organization being represented.
  • A photocopy of official press credentials, such a press card issued by a recognized journalists’ association or a government-sanctioned press organization (IASLC does not recognize press cards issued by web-based organizations such as IFNM) and/or a business card issued by a recognized news organization.

Freelance journalists including photographers may work for multiple publications, as long as they confirm in advance that those publications are eligible for media registration. Freelance journalists must submit the following:

  • A letter of assignment on the letterhead of the news organization being represented.
  • A recent copy of the publication (a mailed copy, link to the publication’s website or a photocopy of a cover/issue published within the past 6 months).
Media Policies

IASLC Press & Embargo Policies

Please read carefully as these policies have been updated for 2020, including:

  1. Abstract Embargo
  2. Press Release Embargo
  3. Social Media
  4. Interview
  5. Video, Photography and Audio Recording
  6. Live Coverage
  7. Presentation Slides and Poster Release
  8. Media List

Abstract Embargo Policy
Abstracts selected for inclusion in the TTLC press program will be kept under embargo until the beginning of the TTLC press conference in which it is presented. All abstracts covered in the TTLC press program will receive a press release. All other abstracts will be made be available online by January 12, 2021 (15:00 PST).

Press Release Policy
Press releases that feature data or events involving the TTLC should include the full name of the meeting, specifically: IASLC 2021 Targeted Therapies of Lung Cancer Meeting hosted by the International Association for the Study of Lung Cancer. Further, we respectfully request that the release include the official conference hashtag: #TTLC21. To learn more, please visit www.iaslc.org.

The IASLC develops press releases for presentations that are selected for the press program. These are to be released at the time the presentation begins or the press conference for that day begins, whichever comes first. Any organization or company issuing a press release about a presentation scheduled for the TTLC press program are asked to hold their releases until after the official IASLC release. If a presentation is selected for the TTLC press program, its content is embargoed until (1) the presentation begins or (2) the press conference for that day begins, whichever comes first. The IASLC welcomes the opportunity to collaborate on a press release for those abstracts selected for the TTLC press program.

Social Media Policy
Organizations may use social media to disseminate news and information regarding abstracts being presented at the TTLC. All information distributed through social media channels must adhere to the IASLC's embargo policy. Please use the IASLC's World Conference hashtag, #TTLC21 in any social media posts. Members of the media are permitted to photograph and transmit/share on any social media platform any presentation's slides without approval from the presenter and/or the IASLC unless explicitly forbidden. However, authors retain the copyright to their full slide presentations and all copyright laws apply to the reproduction, distribution and/or publication of slides. Representatives from academic institutions are permitted to share slides.

Presentation Slides and Poster Release Policy
All presentation slides including audio or video recordings as well as the electronic poster files will be released in the virtual meeting within 24 hours after the presentation but only after the talk or the poster has been presented at the Conference.

Organizations may use social media to disseminate news and information regarding abstracts being presented at the TTLC. All information distributed through social media channels must adhere to the IASLC's embargo policy. Please use the IASLC's World Conference hashtag, #TTLC21 in any social media posts. Members of the media are permitted to photograph or record and transmit/share on any social media platform any presentation's slides without approval from the presenter and/or the IASLC unless explicitly forbidden. However, authors retain the copyright to their full slide presentations and all copyright laws apply to the reproduction, distribution and/or publication of slides. Representatives from academic institutions are permitted to share slides.

Media List Policy
The IASLC does not release media lists for the IASLC 2021 Targeted Therapies of Lung Cancer Meeting.

For questions, please contact:

Chris Martin
VP Public Relations, David James Group
CMartin at DavidJamesGroup.com
Phone: +1 630 670 2745


Jan Mazotti
Associate Director, Marketing and Communications
Jan.Mazotti at iaslc.org



  • Stay Connected

    Keep up to date with the latest news & alerts.
    Sign Up


     
    #TTLC21
© 2021 International Association for the Study of Lung Cancer – IASLC TTLC 2021 | Privacy Notice

Conference Newsletter
Subscribe to the Newsletter to receive important information about the upcoming Meeting.
Thank you! We look forward to connecting soon.
Click here to close this window
Whoops, looks like there was an issue with one of the fields above - please review above.
X